Menu
 
Research menu
Jump to menu

Publications:  Dr Arianna Battisti

Bigogno CM, Falahieh RR, Ho KMA, Jeffrey-Smith A, Jones M, Usai C, Battisti A, Gill U et al.(2020). The genetic landscape of hepatitis delta virus infection. Clin Med (Lond) vol. 20, (Suppl 2)
10.7861/clinmed.20-2-s101
Salpini R, Battisti A, Piermatteo L, Carioti L, Anastasiou OE, Gill US, Di Carlo D, Colagrossi L et al.(2020). Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection. Emerging Microbes and Infections vol. 9, (1) 928-939.
10.1080/22221751.2020.1757998
Gill US, Battisti A, Kennedy PTF(2019). Emerging tools in the changing landscape of chronic hepatitis B management. Expert Review of Anti-Infective Therapy vol. 17, (12) 943-955.
10.1080/14787210.2019.1694906
Piermatteo L, Battisti A, Carioti L, Anastasiou O, Gill US, Colagrossi L, Bertoli A, Aragri M et al. (2019). Specific genetic elements in HBsAg C-terminus profoundly affect HBsAg levels in vivo, hamper HBsAg secretion in vitro and alter HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection. JOURNAL OF HEPATOLOGY. vol. 70, E713-E714.
Svicher V, Salpini R, Battisti A, Colagrossi L, Piermatteo L, Surdo M, Cacciafesta V, Nuccitelli A et al. (2019). The integration of Hepatitis B virus into human genome is a common event in the setting of HBeAg negative disease: Implications for the treatment and management of CHB. JOURNAL OF HEPATOLOGY. vol. 70, E83-E84.
10.1016/S0618-8278(19)30145-8
Piermatteo L, Battisti A, Carioti L, Anastasiou O, Gill US, Colagrossi L, Bertoli A, Aragri M et al. (2019). Key mutations in HBsAg C-terminus correlate with lower HBsAg levels in vivo, hinder HBsAg release in vitro and affect HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection. DIGESTIVE AND LIVER DISEASE. vol. 51, E60-E60.
10.1016/j.dld.2018.11.149
Salpini R, Carioti L, Battisti A, Colagrossi L, Piermatteo L, Surdo M, Cacciafesta V, Nuccitelli A et al. (2019). The integration of Hepatitis B virus into human genome is a common event in the setting of HBeAg negative chronic infection: implications for an altered cell homeostasis and metabolism. DIGESTIVE AND LIVER DISEASE. vol. 51, E14-E14.
10.1016/j.dld.2018.11.062
Colagrossi L, Salpini R, Gill US, Battisti A, Piermatteo L, Carlo DD, Hansi N, Silberstein FC et al. (2018). Basal core promoter mutations as potential predictors of an enlarged intrahepatic HBV reservoir and enhanced cccDNA transcriptional activity in HBeAg negative chronic hepatitis B infection. JOURNAL OF HEPATOLOGY. vol. 68, S484-S484.
10.1016/S0168-8278(18)31218-2
Svicher V, Salpini R, Colagrossi L, Carlo DD, Battisti A, Piermatteo L, Hansi N, Silberstein FC et al. (2018). Combination of HBV serological markers to predict the burden and productivity of intrahepatic HBV reservoir and disease progression in HBeAg negative Chronic Hepatitis B. JOURNAL OF HEPATOLOGY. vol. 68, S482-S482.
10.1016/S0168-8278(18)31213-3
Salpini R, Battisti A, Carioti L, Carlo DD, Anastasiou O, Gill US, Colagrossi L, Bertoli A et al. (2018). Key mutational patterns in HBsAg C-terminus profoundly affect HBsAg levels in HBeAg-negative chronic HBV genotype D infection. JOURNAL OF HEPATOLOGY. vol. 68, S492-S493.
10.1016/S0168-8278(18)31233-9
Salpini R, Colagrossi L, Gill US, Battisti A, Piermatteo L, Hansi N, Perno CF, Kennedy PTF et al. (2018). Combination of HBV serological markers can predict the burden and productivity of intrahepatic HBV reservoir and disease progression in HBeAg-negative chronic hepatitis B infection. DIGESTIVE AND LIVER DISEASE. vol. 50, 13-13.
10.1016/j.dld.2018.01.026
Colagrossi L, Salpini R, Gill US, Battisti A, Piermatteo L, Di Carlo D, Hansi N, Ceccherini-Silberstein F et al. (2018). HBV reservoir and enhanced cccDNA transcriptional activity in HBeAg negative chronic hepatitis B. DIGESTIVE AND LIVER DISEASE. vol. 50, 27-27.
10.1016/j.dld.2018.01.090
Salpini R, Piermatteo L, Gill U, Battisti A, Stazi F, Guenci T, Giannella S, Serafini V et al.(2017). Quantification of intrahepatic total HBV DNA in liver biopsies of HBV-infected patients by a modified version of COBAS<sup>®</sup> Ampliprep/COBAS<sup>®</sup>TaqMan HBV test v2.0. Medical Microbiology and Immunology vol. 206, (4) 295-299.
10.1007/s00430-017-0504-3
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31843
Salpini R, Battisti A, Anastasiou O, Gill U, Colagrossi L, Bertoli A, Fabeni L, Fini V et al. (2017). In HBeAg-negative chronic HBV infection, HBsAg levels profoundly differ among HBV-genotypes and can be affected by the extent of HBsAg variability: Can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?. DIGESTIVE AND LIVER DISEASE. vol. 49, E45-E45.
10.1016/j.dld.2017.01.093
Salpini R, Colagrossi L, Battisti A, Hansi N, Perno CF, Gill US, Kennedy PTF, Svicher V (2017). Peripheral and intrahepatic virological phenotyping in HBeAg negative Chronic Hepatitis B to evaluate risk of disease progression and HCC in the "grey-zone" viral load cohort: Can grey-zone patients be candidate to treatment?. DIGESTIVE AND LIVER DISEASE. vol. 49, E7-E7.
10.1016/j.dld.2017.01.017
Salpini R, Battisti A, Anastasiou O, Gill U, Colagrossi L, Bertoli A, Fabeni L, Fini V et al. (2017). In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?. JOURNAL OF HEPATOLOGY. vol. 66, S470-S470.
10.1016/S0168-8278(17)31327-2
Svicher V, Salpini R, Colagrossi L, Battisti A, Piermatteo L, Hansi N, Perno CF, Gill US et al. (2017). Peripheral and intrahepatic virological phenotyping in eAg negative chronic hepatitis B to evaluate risk of disease progression and hepatocellular carcinoma in the "grey-zone" viral load cohort. JOURNAL OF HEPATOLOGY. vol. 66, S701-S701.
10.1016/S0168-8278(17)31880-9
Return to top